Weight Loss Drug - Wegovy |ForumIAS

ForumIAS LATEST

1. 1. SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
  2. Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
  3. [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
  4. 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →

News: Danish drugmaker Novo Nordisk has launched its weight loss drug Wegovy as a once-a-week injection in India.

About Weight Loss Drug – Wegovy

It is a prescription weight loss drug developed by Danish pharmaceutical company Novo Nordisk.
It contains semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes but found to be highly effective for weight loss.
It is administered as a once-weekly injection using a convenient pen device (FlexiPen or FlexTouch).
The drug is approved by Central Drugs Standard Control Organisation, (CDSCO) in India strictly for obesity management and not for diabetes.

It is made of semaglutide, a GLP 1A receptor agonist, which mimics the naturally occurring hormone GLP-1, responsible for regulating blood sugar, reducing appetite and slowing down gastric emptying.
It makes a person feel fuller for longer and eat less.

Ozempic is used more for diabetes management. The main difference between the two is the dose.
Rybelsus is an oral pill for the same.
Mounjaro is made up of tirzepatide, which mimics the function of natural hormones GIP and GLP-1.
- It has a double effect, of increasing insulin secretion in response to food intake and improving glucose control and weight loss.